A COMPARISON OF PARGYLINE AND TRANYLCYPROMINE WITH AND WITHOUT THE ADDITION OF TRIFLUOPERAZINE:  A DOUBLE-BLIND STUDY.
D035843:Biomedical Research; D001921:Brain; D001925:Brain Damage, Chronic; D003865:Major Depressive Disorder; D004311:Double-Blind Method; D004358:Drug Therapy; D008607:Intellectual Disability; D001523:Mental Disorders; D010259:Paranoid Disorders; D010293:Pargyline; D011618:Psychotic Disorders; D012559:Schizophrenia; D014191:Tranylcypromine; D014268:Trifluoperazine
D014268:Trifluoperazine; D014191:Tranylcypromine; D010293:Pargyline
BRAIN DAMAGE, CHRONIC; CLINICAL RESEARCH; DRUG THERAPY; MENTAL RETARDATION; PARANOIA; PARGYLINE; PSYCHOSES, INVOLUTIONAL; SCHIZOPHRENIA; TRANYLCYPROMINE; TRIFLUOPERAZINE